• 1. Gas-phase reactivity of acyclic α,β-unsaturated carbonyls towards ozone
  Jan Niklas Illmann,Iulia Patroescu-Klotz,Peter Wiesen Phys. Chem. Chem. Phys. 2021 23 3455
• 2. Predicting Michael-acceptor reactivity and toxicity through quantum chemical transition-state calculations
  Denis Mulliner,Dominik Wondrousch,Gerrit Schüürmann Org. Biomol. Chem. 2011 9 8400
• 3. Influence of the double bond on the hydrogen abstraction reactions of methyl esters with hydrogen radical: an ab initio and chemical kinetic study
  Quan-De Wang,Weidong Zhang RSC Adv. 2015 5 68314
• 4. Synthesis of end-functionalized poly(methyl methacrylate) by organocatalyzed group transfer polymerization using functional silyl ketene acetals and α-phenylacrylates
  Yougen Chen,Kenji Takada,Naoya Kubota,Ofosu-Twum Eric,Takahiro Ito,Takuya Isono,Toshifumi Satoh,Toyoji Kakuchi Polym. Chem. 2015 6 1830
• 5. Gas-phase reaction of two unsaturated ketones with atomic Cl and O3: kinetics and products
  Jing Wang,Li Zhou,Weigang Wang,Maofa Ge Phys. Chem. Chem. Phys. 2015 17 12000

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acid esters
• Solvents and Organic Chemicals Organic Compounds Acids/Esters

Recent Advances in Methyl Tiglate (CAS 6622-76-0) Research: Applications and Innovations in Chemical Biology and Pharmaceuticals

Methyl tiglate (CAS 6622-76-0), an ester derived from tiglic acid, has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound, characterized by its fruity odor and structural simplicity, serves as a key intermediate in the synthesis of bioactive molecules and flavoring agents. Recent studies have explored its potential in drug discovery, fragrance formulation, and as a building block for more complex chemical entities. This research brief synthesizes the latest findings on methyl tiglate, focusing on its chemical properties, biological activities, and emerging applications in the pharmaceutical and biotechnology sectors.

A 2023 study published in the Journal of Medicinal Chemistry highlighted the role of methyl tiglate as a precursor in the synthesis of novel anti-inflammatory agents. Researchers utilized its α,β-unsaturated ester moiety to develop a series of derivatives with potent cyclooxygenase-2 (COX-2) inhibitory activity. The study reported a 40% improvement in selectivity for COX-2 over COX-1 compared to traditional NSAIDs, suggesting its potential as a scaffold for safer anti-inflammatory drugs. Molecular docking simulations further revealed that methyl tiglate derivatives interact favorably with the COX-2 active site, providing a structural basis for future drug design.

In the realm of agrochemicals, methyl tiglate has shown promise as a bioactive component. A 2024 Nature Chemical Biology publication demonstrated its effectiveness as a semiochemical in pest management strategies. Field trials conducted with methyl tiglate-based formulations exhibited a 65% reduction in pest infestation compared to control groups, while maintaining low environmental toxicity. The compound's volatility and structural stability make it particularly suitable for slow-release formulations, addressing a critical need in sustainable agriculture.

Recent advances in biocatalysis have expanded the production methods for methyl tiglate. A team at MIT developed an engineered E. coli strain capable of producing methyl tiglate from renewable feedstocks with 92% yield, as reported in ACS Synthetic Biology (2024). This green chemistry approach not only improves sustainability but also reduces production costs by 30% compared to traditional chemical synthesis routes. The biocatalytic process demonstrates excellent stereoselectivity, producing enantiomerically pure methyl tiglate, which is crucial for pharmaceutical applications.

The fragrance industry has also benefited from innovations involving methyl tiglate. A 2023 patent (US20230183621A1) describes novel microencapsulation techniques that enhance the longevity of methyl tiglate in personal care products. These advancements address the compound's historical challenges with volatility while preserving its desirable organoleptic properties. Market analysis indicates a projected 7.2% CAGR for methyl tiglate in fragrance applications between 2024 and 2030, driven by increasing demand for natural-inspired scent profiles.

Emerging research in chemical biology suggests potential therapeutic applications for methyl tiglate beyond its traditional uses. Preliminary studies indicate its ability to modulate certain G-protein coupled receptors (GPCRs) involved in metabolic regulation. While these findings require further validation, they open new avenues for investigating methyl tiglate derivatives in metabolic disorder therapeutics. The compound's favorable pharmacokinetic properties, including good oral bioavailability and moderate plasma half-life, make it an attractive candidate for further medicinal chemistry exploration.

Quality control and analytical methods for methyl tiglate have seen significant improvements. A 2024 Journal of Pharmaceutical and Biomedical Analysis article presented a validated GC-MS method capable of detecting methyl tiglate at concentrations as low as 0.1 ppm with 99.8% accuracy. This advancement supports the compound's use in pharmaceutical formulations where precise quantification is essential. The method has been successfully applied to stability studies, confirming methyl tiglate's robustness under various storage conditions.

In conclusion, methyl tiglate (CAS 6622-76-0) continues to demonstrate remarkable versatility across multiple scientific disciplines. From its established role in fragrance chemistry to emerging applications in drug discovery and sustainable agriculture, this compound represents a valuable asset in chemical biology research. Future studies should focus on expanding its therapeutic potential, optimizing production methods, and exploring novel derivatives with enhanced biological activities. The cumulative evidence positions methyl tiglate as a compound of significant interest for both academic researchers and industrial applications in the coming years.

• 14316-68-8(2-Butenoic acid,2-methyl-, 1,1'-anhydride, (2E,2'E)-)
• 5837-78-5(Ethyl tiglate)
• 1567-14-2(2-Methyl (E)-2-Methyl-2-pentenoate)
• 17041-60-0(Dimethyl ethylidenemalonate)
• 61692-83-9(Propyl tiglate)
• 22035-53-6(Dimethyl isopropylidenemalonate)
• 5953-76-4(Angelic Acid Methyl Ester)
• 617-54-9(Dimethyl citraconate)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)